Has low-dose intracoronary thrombolysis gained ground in primary percutaneous intervention?
Kaddoura R, Mohamed Ibrahim MI, Arabi AR.
Angiology. 2022 Nov 4:33197221138725. doi: 10.1177/00033197221138725. Online ahead of print.
Intracoronary Thrombolysis in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: an Updated Meta-analysis of Randomized Controlled Trials.
Alexiou S, Patoulias D, Theodoropoulos KC, Didagelos M, Nasoufidou A, Samaras A, Ziakas A, Fragakis N, Dardiotis E, Kassimis G.
Cardiovasc Drugs Ther. 2024 Apr;38(2):335-346. doi: 10.1007/s10557-022-07402-3. Epub 2022 Nov 8.
Safety and efficacy of low-dose intracoronary thrombolysis during primary percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis of randomized trials.
Sahami N, Akl E, Sanjanwala R, Shah AH.
Curr Probl Cardiol. 2024 Aug;49(8):102616. doi: 10.1016/j.cpcardiol.2024.102616. Epub 2024 May 6.
Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study.
Singh R, Singla SK, Singla A, Manchanda S, Kaur M.
Int J Appl Basic Med Res. 2022 Oct-Dec;12(4):260-264. doi: 10.4103/ijabmr.ijabmr_407_22. Epub 2022 Dec 19.
Intracoronary thrombolysis and stentless primary percutaneous coronary intervention in an ectatic right coronary artery with large thrombus burden.
Kassimis G, Faliagkas P, Pshochias P, Karagiannidis E, Peteinidou E, Chatzinikolaou E, Ziakas A, Sianos G.
Future Cardiol. 2021 Sep;17(6):999-1006. doi: 10.2217/fca-2020-0141. Epub 2020 Dec 10.
Novel Therapeutic Strategies to Reduce Reperfusion Injury After Acute Myocardial Infarction.
Schäfer A, König T, Bauersachs J, Akin M.
Curr Probl Cardiol. 2022 Dec;47(12):101398. doi: 10.1016/j.cpcardiol.2022.101398. Epub 2022 Sep 13.
Intracoronary arterial retrograde thrombolysis with percutaneous coronary intervention: a novel use of thrombolytic to treat acute ST-segment elevation myocardial infarction.
Tian JW, Zhu M, Wang FQ, Li K, Zhou CF, Li B, Wang M, Deng JL, Jiang B, Bai J, Guo Y, Jin RJ, Zhang Z, Lin Y, Wang JH, Zhao SH, Shen MZ.
J Geriatr Cardiol. 2019 Jun;16(6):458-467. doi: 10.11909/j.issn.1671-5411.2019.06.004.
Intracoronary artery retrograde thrombolysis combined with percutaneous coronary interventions for ST-segment elevation myocardial infarction complicated with diabetes mellitus: A case report and literature review.
Shen M, Liao Y, Wang J, Zhou X, Guo Y, Nong Y, Guo Y, Lu H, Jin R, Wang J, Fu Z, Li D, Zhao S, Tian J.
Front Cardiovasc Med. 2022 Jul 22;9:962127. doi: 10.3389/fcvm.2022.962127. eCollection 2022.
Improving STEMI Reperfusion with Intracoronary Thrombolysis: A Way to "Go with the Flow".
Davis DO MG, Blankenship JC.
Cardiovasc Drugs Ther. 2024 Apr;38(2):209-210. doi: 10.1007/s10557-023-07471-y. Epub 2023 May 18.
Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial.
Pelliccia F, Greco C, Tanzilli G, Viceconte N, Schiariti M, Gaudio C.
J Thromb Thrombolysis. 2021 Jan;51(1):212-216. doi: 10.1007/s11239-020-02157-w.
